SCHEMBL5745742

SCHEMBL5745742

Cc1cc(CC(C)N(C(=O)OO)C(C)(C)C)cc2cn(COCC[Si](C)(C)C)nc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5809034 0.84 KLKB1 (0.30) —
SCHEMBL4513127 0.82 — —
SCHEMBL4501272 0.81 — —
SCHEMBL2973490 0.78 KLKB1 (0.33) —
SCHEMBL2973484 0.78 KLKB1 (0.33) —
SCHEMBL4518154 0.77 — —
SCHEMBL13203919 0.76 F11 (0.32) —
SCHEMBL2980926 0.76 F11 (0.32) —
SCHEMBL2427195 0.76 KLKB1 (0.32) —
SCHEMBL4507520 0.76 KLKB1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1689738-A2 HETEROCYCLIC ANTI-MIGRAINE AGENTS Bristol-Myers Squibb Company (US) 2006-08-16 — — EP disclosed
WO-2005056550-A2 HETEROCYCLIC ANTI-MIGRAINE AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-06-23 — — WO disclosed
Send feedback